Christopher T. Lemke

1.3k total citations
27 papers, 647 citations indexed

About

Christopher T. Lemke is a scholar working on Infectious Diseases, Hepatology and Molecular Biology. According to data from OpenAlex, Christopher T. Lemke has authored 27 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 9 papers in Hepatology and 8 papers in Molecular Biology. Recurrent topics in Christopher T. Lemke's work include HIV/AIDS drug development and treatment (14 papers), Hepatitis C virus research (9 papers) and HIV Research and Treatment (8 papers). Christopher T. Lemke is often cited by papers focused on HIV/AIDS drug development and treatment (14 papers), Hepatitis C virus research (9 papers) and HIV Research and Treatment (8 papers). Christopher T. Lemke collaborates with scholars based in Canada, United States and Egypt. Christopher T. Lemke's co-authors include Nathalie Goudreau, P. Lynne Howell, Steve Titolo, Stephen W. Mason, Anne‐Marie Faucher, Stephen H. Kawai, Soma S. R. Banik, Elizabeth Wardrop, Wesley I. Sundquist and Oliver Hucke and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Journal of Virology.

In The Last Decade

Christopher T. Lemke

26 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher T. Lemke Canada	15	291	287	276	112	90	27	647
Chen‐Hsiang Shen United States	15	271 0.9×	321 1.1×	362 1.3×	67 0.6×	86 1.0×	33	653
Ayşegül Özen United States	16	309 1.1×	373 1.3×	249 0.9×	51 0.5×	202 2.2×	22	744
James A. Nieman Canada	18	392 1.3×	293 1.0×	217 0.8×	448 4.0×	27 0.3×	28	1.1k
Nashaat T. Nashed United States	17	360 1.2×	364 1.3×	287 1.0×	179 1.6×	16 0.2×	33	762
S.L. Irving United Kingdom	7	326 1.1×	186 0.6×	218 0.8×	152 1.4×	22 0.2×	8	547
Francesca Curreli United States	19	431 1.5×	503 1.8×	415 1.5×	222 2.0×	143 1.6×	38	1.2k
Alexej Dick United States	16	310 1.1×	388 1.4×	224 0.8×	216 1.9×	50 0.6×	38	932
Stuart C. Findlow United Kingdom	9	303 1.0×	113 0.4×	142 0.5×	87 0.8×	18 0.2×	11	476
Luke A. Pallansch United States	15	352 1.2×	314 1.1×	347 1.3×	62 0.6×	51 0.6×	24	763
Chin Ho Chen United States	14	242 0.8×	459 1.6×	446 1.6×	198 1.8×	46 0.5×	23	760

Countries citing papers authored by Christopher T. Lemke

Since Specialization

Citations

This map shows the geographic impact of Christopher T. Lemke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher T. Lemke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher T. Lemke more than expected).

Fields of papers citing papers by Christopher T. Lemke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher T. Lemke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher T. Lemke. The network helps show where Christopher T. Lemke may publish in the future.

Co-authorship network of co-authors of Christopher T. Lemke

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher T. Lemke. A scholar is included among the top collaborators of Christopher T. Lemke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher T. Lemke. Christopher T. Lemke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rubinson, Douglas A., Noritaka Tanaka, Ferran Fece de la Cruz, et al.. (2024). Sotorasib Is a Pan- RAS G12C Inhibitor Capable of Driving Clinical Response in NRAS G12C Cancers. Cancer Discovery. 14(5). 727–736. 23 indexed citations

Serrano‐Wu, Michael H., Georgios Kosmidis, Stefan Kaulfuß, et al.. (2023). Abstract 506: ANJ810 is a highly selective novel MCL1 inhibitor with optimized in vivo clearance showing robust efficacy in preclinical solid and hematological tumor models. Cancer Research. 83(7_Supplement). 506–506. 1 indexed citations

Orsi, Douglas L., Elisabeth Pook, Anders Friberg, et al.. (2022). Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069. Journal of Medicinal Chemistry. 65(21). 14843–14863. 9 indexed citations

Goudreau, Nathalie, René Coulombe, Anne‐Marie Faucher, et al.. (2013). Monitoring Binding of HIV‐1 Capsid Assembly Inhibitors Using ¹⁹F Ligand‐and ¹⁵N Protein‐Based NMR and X‐ray Crystallography: Early Hit Validation of a Benzodiazepine Series. ChemMedChem. 8(3). 405–414. 14 indexed citations

Bailey, Murray D., Josée Bordeleau, Michel Garneau, et al.. (2013). Peptide backbone replacement of hepatitis C virus NS3 serine protease C-terminal cleavage product analogs: Discovery of potent succinamide inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(15). 4447–4452.

Bilodeau, François, Murray D. Bailey, Josée Bordeleau, et al.. (2013). Synthesis and optimization of a novel series of HCV NS3 protease inhibitors: 4-Arylproline analogs. Bioorganic & Medicinal Chemistry Letters. 23(14). 4267–4271. 4 indexed citations

Fader, Lee D., Serge Landry, Sébastien Morin, et al.. (2013). Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 1: Addressing configurational instability through scaffold modification. Bioorganic & Medicinal Chemistry Letters. 23(11). 3396–3400. 15 indexed citations

Lemke, Christopher T., Steve Titolo, Nathalie Goudreau, et al.. (2013). A novel inhibitor-binding site on the HIV-1 capsid N-terminal domain leads to improved crystallizationviacompound-mediated dimerization. Acta Crystallographica Section D Biological Crystallography. 69(6). 1115–1123. 27 indexed citations

Bailey, Murray D., et al.. (2013). Discovery of novel P2 substituted 4-biaryl proline inhibitors of hepatitis C virus NS3 serine protease. Bioorganic & Medicinal Chemistry Letters. 23(15). 4436–4440. 1 indexed citations

10.

LaPlante, Steven R., Herbert Nar, Christopher T. Lemke, et al.. (2013). Ligand Bioactive Conformation Plays a Critical Role in the Design of Drugs That Target the Hepatitis C Virus NS3 Protease. Journal of Medicinal Chemistry. 57(5). 1777–1789. 36 indexed citations

11.

O’Meara, Jeff A., Christopher T. Lemke, Cédrickx Godbout, et al.. (2012). Molecular Mechanism by Which a Potent Hepatitis C Virus NS3-NS4A Protease Inhibitor Overcomes Emergence of Resistance. Journal of Biological Chemistry. 288(8). 5673–5681. 11 indexed citations

12.

Tremblay, Martin, Pierre Bonneau, Yves Bousquet, et al.. (2012). Inhibition of HIV-1 capsid assembly: Optimization of the antiviral potency by site selective modifications at N1, C2 and C16 of a 5-(5-furan-2-yl-pyrazol-1-yl)-1H-benzimidazole scaffold. Bioorganic & Medicinal Chemistry Letters. 22(24). 7512–7517. 28 indexed citations

13.

Lemke, Christopher T., Nathalie Goudreau, Songping Zhao, et al.. (2011). Combined X-ray, NMR, and Kinetic Analyses Reveal Uncommon Binding Characteristics of the Hepatitis C Virus NS3-NS4A Protease Inhibitor BI 201335. Journal of Biological Chemistry. 286(13). 11434–11443. 38 indexed citations

14.

Lemke, Christopher T., et al.. (2010). Structure of the Antibiotic Resistance Factor Spectinomycin Phosphotransferase from Legionella pneumophila. Journal of Biological Chemistry. 285(13). 9545–9555. 36 indexed citations

15.

Naud, Julie, et al.. (2008). Potent triazolyl-proline-based inhibitors of HCV NS3 protease. Bioorganic & Medicinal Chemistry Letters. 18(11). 3400–3404. 24 indexed citations

16.

Smith, G. David, Christopher T. Lemke, & P. Lynne Howell. (2006). Substructure Determination in Multiwavelength Anomalous Diffraction, Single Anomalous Diffraction, and Single Isomorphous Replacement With Anomalous Scattering Data Using <i>Shake-and-Bake</i>. Humana Press eBooks. 364. 183–196. 2 indexed citations

17.

Lemke, Christopher T., Ji‐Young Hwang, Bing Xiong, Nicholas P. Cianciotto, & Albert M. Berghuis. (2005). Crystallization and preliminary crystallographic analysis of an aminoglycoside kinase fromLegionella pneumophila. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 61(6). 606–608. 3 indexed citations

18.

Lemke, Christopher T., G. David Smith, & P. Lynne Howell. (2002). S-SAD, Se-SAD and S/Se-SIRAS using Cu Kα radiation: why wait for synchrotron time?. Acta Crystallographica Section D Biological Crystallography. 58(12). 2096–2101. 12 indexed citations

19.

Lemke, Christopher T. & P. Lynne Howell. (2002). Substrate Induced Conformational Changes in Argininosuccinate Synthetase. Journal of Biological Chemistry. 277(15). 13074–13081. 19 indexed citations

20.

Lemke, Christopher T. & P. Lynne Howell. (2001). The 1.6 Å Crystal Structure of E. coli Argininosuccinate Synthetase Suggests a Conformational Change during Catalysis. Structure. 9(12). 1153–1164. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact